Cogent Biosciences
(NASDAQ) COGT
Cogent Biosciences Financials at a Glance
Market Cap
$5.72B
Revenue (TTM)
$0.00
Net Income (TTM)
$328.94M
EPS (TTM)
$-2.56
P/E Ratio
-13.76
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$35.31
Volume
75,809
Open
$34.39
Price
$35.31
Volume
75,809
Open
$34.39
Previous Close
$35.31
Daily Range
$33.89 - $35.64
52-Week Range
$3.72 - $43.73
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$35.31
Volume
75,809
Open
$34.39
Previous Close
$35.31
Daily Range
$33.89 - $35.64
52-Week Range
$3.72 - $43.73
COGT News
COGT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cogent Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
258
CEO
Andrew R. Robbins, MBA
Website
www.cogentbio.comHeadquarters
Waltham, MA 02140, US
COGT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-74%
Return on Capital
-38%
Return on Assets
-35%
Earnings Yield
-7.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.72B
Shares Outstanding
162.38M
Volume
75.81K
Short Interest
0.00%
Avg. Volume
2.19M
Financials (TTM)
Gross Profit
$4.62M
Operating Income
$333.36M
EBITDA
$328.74M
Operating Cash Flow
$264.44M
Capital Expenditure
$1.55M
Free Cash Flow
$266.00M
Cash & ST Invst.
$900.76M
Total Debt
$253.15M
Cogent Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.18M
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.72B
N/A
Market Cap/Employee
$27.89M
N/A
Employees
205
N/A
Net Income
$102.49M
-50.9%
EBITDA
$108.68M
-49.6%
Quarterly Fundamentals
Net Cash
$647.61M
+140.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$251.60M
+1482.2%
Short Term Debt
$1.55M
-1.2%
Return on Assets
-35.08%
N/A
Return on Invested Capital
-38.16%
N/A
Free Cash Flow
$79.92M
-31.8%
Operating Cash Flow
$79.11M
-30.6%